Share this article
Share this article
Osteopore and Maastricht University Medical Centre has developed a first-of-its-kind, bioresorbable bone implant solution that prevents leg amputations in patients with severe lower leg fractures
Osteopore and National Additive Manufacturing Innovation Cluster have formed a partnership to upscale clinical adoption in Additive Manufacturing
SINGAPORE, Jan. 27, 2021 /PRNewswire/ Osteopore International, a Singapore homegrown company that specialises in 3D printed bioresorbable implants, in collaboration with Maastricht University Medical Centre (UMC+), has successfully developed a bioresorbable 3D printed cage that prevents leg amputations in patients with severe lower leg fractures. The 3D printed cage helps a patient regenerate new bone cells and has been successfully designed and implanted in its first patient in the Netherlands.